Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-02-10 Cohen Chad M Chief Financial Officer Sale −16,721 $31.44 $526K 1,000
2020-02-10 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −20,000 60,000
2020-01-29 ROBINS CHAD M CEO and Chairman Option exercise +11,120 $0.33 $4K 1,889,300
2020-01-29 ROBINS CHAD M CEO and Chairman Sale −11,120 $30.99 $345K 1,878,180
2020-01-29 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −11,120 746,400
2020-01-28 VIKING GLOBAL PERFORMANCE LLC 10% owner Sale −4,912,899 $24.98 $122.7M 33,493,708
2020-01-28 VIKING GLOBAL INVESTORS LP 10% owner Sale −4,912,899 $24.98 $122.7M 33,493,708
2020-01-28 ROBINS CHAD M CEO and Chairman Option exercise +11,120 $0.33 $4K 1,889,300
2020-01-28 ROBINS CHAD M CEO and Chairman Sale −10,320 $31.08 $321K 1,878,980
2020-01-28 ROBINS CHAD M CEO and Chairman Sale −800 $31.90 $26K 1,878,180
2020-01-28 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −11,120 757,600
2020-01-28 ZOLTNERS ANDRIS A Director Option exercise +100,000 $0.16 $16K 3,966,016
2020-01-28 ZOLTNERS ANDRIS A Director Sale −345,000 $26.50 $9.1M 3,621,016
2020-01-28 ZOLTNERS ANDRIS A Director Option exercise · Stock Option (Right to Buy) −100,000 0
2020-01-27 ROBINS CHAD M CEO and Chairman Option exercise +11,120 $0.33 $4K 1,889,300
2020-01-27 ROBINS CHAD M CEO and Chairman Sale −11,120 $30.01 $334K 1,878,180
2020-01-27 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −11,120 768,800
2020-01-24 GOEL DAVID E. Director Conversion −2,217,101 $26.50 $58.8M 15,115,090
2020-01-17 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,700 $6.32 $23K 74,379
2020-01-17 ROBINS HARLAN S Chief Scientific Officer Sale −1,300 $27.33 $36K 73,079

Page 114 of 120 · 2,386 trades